- Subject who completed the A1481244 study and are judged by the Investigator to derive
clinical benefit from continuous treatment with Sildenafil 20 mg therapy.
- Subject who resides in a Brazilian State where Sildenafil is not supplied by State
- Pregnant or lactating women.
- Current participation in other studies and during study participation.